UK MHRA · November 03, 2025

Guidance: Regulatory considerations for therapeutic use of bacteriophages in the UK

MHRA clarifies which regulatory guidelines apply to development of phage therapeutic products in the UK.

Medium impact Pharmaceuticals Clinical Trials & Research UK pharmaceuticalsclinical-trials

This publication clarifies which regulatory guidelines should be followed, and which apply, in the development of phage therapeutic products.

Read the official source ↗

Published by UK MHRA. HealthSignal links to the original document; the summary above is extracted from the source text.